List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 425 studies with search of: "Abbott" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab
2 Active, not recruiting Adalimumab in Adult Japanese Subjects With Psoriasis
Condition: Psoriasis
Interventions: Biological: adalimumab;   Biological: adalimumab
3 Completed A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Nelfinavir mesylate
4 Completed Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension
Condition: Hypertension
Intervention: Drug: trandolapril/verapamil
5 Active, not recruiting Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain
Condition: Healthy Volunteers
Intervention: Drug: ABT-614
6 Completed A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
Condition: Breast Cancer
Intervention: Drug: ABT-751
7 Active, not recruiting Efficacy, Safety, Immunogenicity and Effect on Immune Response of Adalimumab Following Subcutaneous Administration in Patients With Active RA Treated Concomitantly With MTX.
Condition: Rheumatoid Arthritis
Interventions: Biological: adalimumab;   Biological: adalimumab;   Drug: placebo
8 Active, not recruiting A Study to Assess the Safety and Efficacy of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo;   Biological: Adalimumab 40 mg;   Biological: Adalimumab 80 mg
9 Active, not recruiting Open Label Continuation Study in Moderate to Severe Psoriasis
Condition: Moderate to Severe Plaque Psoriasis
Intervention: Drug: ABT-874
10 Recruiting The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With CKD Stage 5
Conditions: Chronic Kidney Disease Stage 5;   Left Ventricular Hypertrophy
Interventions: Drug: paricalcitol injection;   Drug: placebo injection
11 Recruiting Bioavailability of ABT-333 Tablet Versus FIH Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers
Condition: HCV Infection
Interventions: Drug: ABT-333;   Drug: Placebo
12 Completed Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media
Condition: Acute Otitis Media
Intervention: Drug: cefdinir
13 Completed Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.
Condition: Acute Heart Failure
Interventions: Drug: levosimendan;   Drug: dobutamine
14 Recruiting Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ABT-089;   Drug: ABT-089;   Drug: ABT-089;   Drug: ABT-089;   Drug: ABT-089;   Drug: ABT-089;   Drug: placebo
15 Completed Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects
Condition: HCV Infection
Interventions: Drug: ABT-333;   Drug: Placebo
16 Withdrawn Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors
Condition: Solid Tumors
Interventions: Drug: ABT-869;   Drug: Tarceva
17 Completed An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
Condition: Bipolar Disorder
Intervention: Drug: Divalproex Sodium (Depakote ER)
18 Completed Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: adalimumab;   Drug: placebo for adalimumab
19 Active, not recruiting Long-Term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)
Conditions: Secondary Hyperparathyroidism;   Hemodialysis
Intervention: Drug: paricalcitol
20 Not yet recruiting Safety Study of ABT-263 in Combination With Carbo-Taxol (Carboplatin/Paclitaxel) in Subjects With Solid Tumors
Condition: Solid Tumor
Interventions: Drug: ABT-263;   Drug: paclitaxel;   Drug: Carboplatin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services